Product Images Ermeza

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Ermeza NDC 49502-378 by Mylan Specialty L.p., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Levothyroxine Sodium Structural Formula - image 01

Levothyroxine Sodium Structural Formula - image 01

mcg dosage to mL conversion - image 02

mcg dosage to mL conversion - image 02

This text provides information on dosage measurement equivalence between milliliters and micrograms, stating that a dosage of 30 mcg is equal to a dosage of 30 mL.*

Instructions for Use Figure A - image 03

Instructions for Use Figure A - image 03

The text describes Figure A, which is a diagram showing two oral syringes, a 5mL syringe, and a 10mL syringe. The syringes have a plunger and a barrel and are used to measure the prescribed dose of medication. The text advises using the graduation markings to measure accurately. Therefore, the text serves as a guide for properly using an oral syringe while administering medication.*

Instructions for Use Figure B - image 04

Instructions for Use Figure B - image 04

Instructions for Use Figure C - image 05

Instructions for Use Figure C - image 05

Instructions for Use Figure D - image 06

Instructions for Use Figure D - image 06

mcg dosage to mL conversion - image 07

mcg dosage to mL conversion - image 07

This is a simple conversion formula indicating that the dosage in micrograms (mcg) is equivalent to the dosage in milliliters (mL) and the specific conversion value is not given.*

Ermeza Oral Solution 150 mcg/5 mL Carton Label - image 08

Ermeza Oral Solution 150 mcg/5 mL Carton Label - image 08

Ermeza is an oral solution of Levothyroxine sodium prescribed for oral administration only. The usual dosage information is available on the accompanying prescribing information. The medication should be stored and dispensed only in the original bottle and protected from light. The solution contains Levothyroxine sodium, USP 150 mcg/ 5mL (30 mcg/mL) and is available in 5mL and 10mL oral syringes. It is manufactured for Hylan Specialty LP and the trademark is owned by Viatris Inc. The medication should be used within 90 days of opening the bottle and kept out of the reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.